You are here

LeanLife Health Inc.

Listing Exchange: 
CSE
Status: 
Delisted
Industry: 
Diversified Industries
Symbol: 
LLP
CSE Index: 
Currency: 

LeanLife’s products are shelf-stable extractions from flaxseed, a plentiful plant-based source of Omega-3, that give them a significant advantage as a fortified food ingredient.  The products can be used as food additives or as nutraceuticals.  They have been used to make bread, noodles, cheese, yogurt, juice and milk products for the European market.  LeanLife Health’s industry leading and proprietary Omega-3 product formulations are of the highest quality and contain no cholesterol. Products are available in oil, emulsion and powder forms.

You are here

LeanLife Health Inc. (LLP)

SEDAR Information

Company Info

Address
580 Hornby Street, Suite 380
Vancouver, BC V6C 3B6
Canada
Phone
1-888-521-0872
Fax
604-608-5442
Email
info@leanlifehealth.com
Website
http://www.Leanlifehealth.com
Listing date
Wednesday, December 17, 2014
Transfer Agent
National Securities Administrators Ltd.
Investor Relations
Stan Lis
Email
info@leanlifehealth.com
Auditor
Charlton & Company

Capitalization

Issued & Outstanding: 
230884851
Reserved for Issuance: 
29935000

Company Officers

Stan Lis, CEO and Director
Casey Forward, Interim CFO
Carl F. Perez, CTO
Marcin Łukaszewicz, Director
Glen Macdonald, Director
Robert Hall, Director

Bulletins

19/06/2024

2024-0621 - Delist - LeanLife Health Inc. (LLP)

le 19 juin/June 2024

The common shares of LeanLife Health Inc. will be delisted from the CSE at market close today, June 19, 2024.

LeanLife Health Inc. is currently suspended. See Bulletin 2022-0810.

___________________________